Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SOBECKS R")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 26

  • Page / 2
Export

Selection :

  • and

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantationBOLWELL, B; SOBECKS, R; POHLMAN, B et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 7, pp 621-625, issn 0268-3369, 5 p.Article

Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantationSOBECKS, R. M; LE BEAU, M. M; ANASTASI, J et al.Bone marrow transplantation (Basingstoke). 1999, Vol 23, Num 11, pp 1161-1165, issn 0268-3369Article

Prevalence and classification of anemia in elective orthopedic surgery patients : implications for blood conservation programsGOODNOUGH, L. T; VIZMEG, K; SOBECKS, R et al.Vox sanguinis (Basel. 1956). 1992, Vol 63, Num 2, pp 90-95, issn 0042-9007Article

CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimensKALAYCIO, M; RYBICKI, L; POHLMAN, B et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 3, pp 247-252, issn 0268-3369, 6 p.Article

Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF aloneBOLWELL, B; SOBECKS, R; POHLMAN, B et al.Bone marrow transplantation (Basingstoke). 2003, Vol 31, Num 2, pp 95-98, issn 0268-3369, 4 p.Article

Syngeneic graft-versus-host disease: a report of two cases and literature reviewLATIF, T; POHLMAN, B; KALAYCIO, M et al.Bone marrow transplantation (Basingstoke). 2003, Vol 32, Num 5, pp 535-539, issn 0268-3369, 5 p.Article

Autologous hematopoietic cell transplantation non-Hodgkin's lymphoma: 100 month follow-upBOLWELL, B; KALAYCIO, M; SOBECKS, R et al.Bone marrow transplantation (Basingstoke). 2002, Vol 29, Num 8, pp 673-679, issn 0268-3369Article

Are backup BM harvests worthwhile in unrelated donor allogeneic transplants?STOTLER, C; BOLWELL, B; SOBECKS, R et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 1, pp 49-52, issn 0268-3369, 4 p.Article

Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantationHAMILTON, B. K; BOLWELL, B; HILL, B et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 12, pp 1578-1580, issn 0268-3369, 3 p.Article

Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemiaMAHINDRA, A; BOLWELL, B. J; POHLMAN, B et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 2, pp 231-235, issn 0268-3369, 5 p.Article

Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDSSOBECKS, R. M; RYBICKI, L; YURCH, M et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 5, pp 633-638, issn 0268-3369, 6 p.Article

Apheresis days required for harvesting CD34 + cells predicts hematopoietic recovery and survival following autologous transplantationMALIK, S; BOLWELL, B; ANDRESEN, S et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 12, pp 1519-1525, issn 0268-3369, 7 p.Article

400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantationSOBECKS, R. M; DEAN, R; CHERNI, K et al.Bone marrow transplantation (Basingstoke). 2008, Vol 42, Num 11, pp 715-722, issn 0268-3369, 8 p.Article

Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphomaKANG, T. Y; RYBICKI, L. A; POHLMAN, B et al.Bone marrow transplantation (Basingstoke). 2007, Vol 40, Num 10, pp 973-978, issn 0268-3369, 6 p.Article

Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma : graft content and post transplant recovery predict survivalDEAN, R; MASCI, P; KALAYCIO, M et al.Bone marrow transplantation (Basingstoke). 2005, Vol 36, Num 12, pp 1049-1052, issn 0268-3369, 4 p.Article

Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction?TANG, W. H. W; THOMAS, S; KALAYCIO, M et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 7, pp 603-607, issn 0268-3369, 5 p.Article

Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCTMICKELSON, D. M; SPROAT, L; COPELAN, E. A et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 1, pp 84-89, issn 0268-3369, 6 p.Article

Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimenSMITH, S. D; BOLWELL, B. J; SWEETENHAM, J. W et al.Bone marrow transplantation (Basingstoke). 2007, Vol 40, Num 3, pp 239-243, issn 0268-3369, 5 p.Article

Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemiaKALAYCIO, M; RYBICKI, L; BOLWELL, B et al.Bone marrow transplantation (Basingstoke). 2007, Vol 40, Num 8, pp 753-758, issn 0268-3369, 6 p.Article

Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantationMOSSAD, S. B; AVERY, R. K; BOLWELL, B. J et al.Bone marrow transplantation (Basingstoke). 2001, Vol 28, Num 5, pp 491-495, issn 0268-3369Article

Quality of life and outcomes in patients ≥ 60 years of age after allogeneic hematopoietic cell transplantationHAMILTON, B. K; RYBICKI, L; DUONG, H et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 11, pp 1426-1431, issn 0268-3369, 6 p.Article

A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphomaCOPELAN, E; POHLMAN, B; BOLWELL, B et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 2, pp 101-105, issn 0268-3369, 5 p.Article

Patients mobilizing large numbers of CD34 + cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignanciesBOLWELL, B. J; POHLMAN, B; SWEETENHAM, J. W et al.Bone marrow transplantation (Basingstoke). 2007, Vol 40, Num 5, pp 437-441, issn 0268-3369, 5 p.Article

The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilizationAVERY, R. K; POHLMAN, B. L; OSTENDORF, H et al.Bone marrow transplantation (Basingstoke). 2002, Vol 30, Num 5, pp 311-314, issn 0268-3369, 4 p.Article

p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemiaNG, K. P; EBRAHEM, Q; SEKERES, M et al.Leukemia. 2011, Vol 25, Num 11, pp 1739-1750, issn 0887-6924, 12 p.Article

  • Page / 2